Clinical Trial Update: Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy Dosing Immunoglobulin (Dose Ig) [Phase 2, Phase 3]

View source ↗

Summary

A Monash University trial is testing antibiotic therapy or intravenous immunoglobulin dosing to prevent infections in hematologic cancer patients, in Phase 2 an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia
• Multiple Myeloma
• Non-hodgkin Lymphoma

Drugs mentioned

• Antibiotic therapy (antibiotics)
• Intravenous Immunoglobulin (IVIG)

Snippet

Sponsor: Monash University | Conditions: Myeloma, Non Hodgkin's Lymphoma | Phase 2, Phase 3 | Status: RECRUITING